Trial intelligence / Profile preview

QL Block vs ESP Block for Analgesia in Lower Abdominal Surgery

NCT05524038Completed

Sponsor
Fayoum University Hospital
Start
Sep 2021
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Morphine consumption at 24 hours. Started Sep 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05524038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05524038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call